Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 567

The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

Open access
Murugaiyan, Jayaseelan, Kumar, P. Anand, Rao, G. Srinivasa, Iskandar, Katia, Hawser, Stephen, Hays, John P., Mohsen, Yara, Adukkadukkam, Saranya, Awuah, Wireko Andrew, Jose, Ruiz Alvarez Maria, Sylvia, Nanono, Nansubuga, Esther Patience, Tilocca, Bruno, Roncada, Paola, Roson-Calero, Natalia, Moreno-Morales, Javier, Amin, Rohul, Kumar, Ballamoole Krishna, Kumar, Abishek, Toufik, Abdul-Rahman, Zaw, Thaint Nadi, Akinwotu, Oluwatosin O., Satyaseela, Maneesh Paul, van Dongen, Maarten B. M.·2022·Antibiotics
DOI 10.3390/antibiotics11020200
Open this paper in CoChat — free account

Abstract

Antibiotic resistance, and, in a broader perspective, antimicrobial resistance (AMR), continues to evolve and spread beyond all boundaries. As a result, infectious diseases have become more challenging or even impossible to treat, leading to an increase in morbidity and mortality. Despite the failure of conventional, traditional antimicrobial therapy, in the past two decades, no novel class of antibiotics has been introduced. Consequently, several novel alternative strategies to combat these (multi-) drug-resistant infectious microorganisms have been identified. The purpose of this review is to gather and consider the strategies that are being applied or proposed as potential alternatives to traditional antibiotics. These strategies include combination therapy, techniques that target the enzymes or proteins responsible for antimicrobial resistance, resistant bacteria, drug delivery systems, physicochemical methods, and unconventional techniques, including the CRISPR-Cas system. These alternative strategies may have the potential to change the treatment of multi-drug-resistant pathogens in human clinical settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics11020200

Cites

315 of 315 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 315 references

Cited by

See all 567

Metadata

Authors
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., Sylvia, N., Nansubuga, E. P., Tilocca, B., Roncada, P., Roson-Calero, N., Moreno-Morales, J., Amin, R., Kumar, B. K., Kumar, A., Toufik, A.-R., Zaw, T. N., Akinwotu, O. O., Satyaseela, M. P., & van Dongen, M. B. M.
Venue
Antibiotics
Publisher
MDPI AG
Published
2022-02-04
Volume
11
Issue
2
Pages
200
ISSN
2079-6382 (ISSN-L)
DOI
10.3390/antibiotics11020200
OpenAlex
W4210396642
Cited by
567
References
315
FWCI
31.82
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. https://app.cochat.ai/papers/10.3390/antibiotics11020200
The paper
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., Sylvia, N., Nansubuga, E. P., Tilocca, B., Roncada, P., Roson-Calero, N., Moreno-Morales, J., Amin, R., Kumar, B. K., Kumar, A., . . . van Dongen, M. B. M. (2022). Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. Antibiotics. https://doi.org/10.3390/antibiotics11020200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.